Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Codal Synto Ltd, 21 Constantinoupoleos street, 3011 Limassol, Cyprus
Taks 75mg/3ml solution for injection or infusion.
| Pharmaceutical Form |
|---|
|
Solution for injection or infusion. Taks is a sterile clear colourless or slightly yellow solution for intramuscular injection or for preparing an intravenous infusion. |
Each ml of solution contains 25mg of diclofenac sodium.
Excipients with known effect: benzyl alcohol (52.35mg/ml), propylene glycol (0.63mg/ml), sodium metabisulphite (0.5mg/ml).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
| List of Excipients |
|---|
|
Taks solution for injection or infusion is presented in single use amber type 1 glass ampoule containing 3ml of diclofenac sodium 25mg/ml, in packs of five or ten ampoules.
Codal Synto Ltd, 21 Constantinoupoleos street, 3011 Limassol, Cyprus
19824
29/12/2005 / 14/09/2011
| Drug | Countries | |
|---|---|---|
| TAKS | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
